New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Germany may have the answer for reducing drug prices

11 September 2019 - American lawmakers attempting to stem spiraling drug costs might find inspiration in Germany, where the government’s ...

Read more →

Canada releases final amendments to patented medicines pricing regulations

9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...

Read more →

Trudeau’s drug price overhaul is set to cost drug makers billions

6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...

Read more →

How a powerful lobby group is pushing up PBS medicine prices

30 August 2019 - Aussies are being forced to pay up to six times more for vital medicines despite being listed ...

Read more →

Drug-price reforms need not affect research on rare diseases – or the Canadians who have them

26 August 2019 - On 9 August, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for ...

Read more →

Companies file suit in Canada challenging new rules to lower drug prices

23 August 2019 - Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging ...

Read more →

ABPI position on US trade deal and medicines pricing

21 August 2019 - In response to concerns about the impact a US trade deal would have on medicine pricing, ...

Read more →

Empirical evidence supports critics of Patented Medicine Prices Review Board regulations

21 August 2019 - Canadian Health Policy Institute, a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster ...

Read more →

What will PMPRB drug pricing changes mean for plan sponsors?

15 August 2019 - Private plan sponsors can expect to see lower drug prices resulting from recent changes to the ...

Read more →

Canadians benefitting from substantially lower generic drug prices

14 August 2019 - Latest agreement between public payers and the Canadian generic industry closes gap with international prices. ...

Read more →

Drug company Aspen may pay NHS £8 million after investigation alleges illegal deal to hike drug price

14 August 2019 - The drug company Aspen may have to pay the NHS £8 million (€8.7 million ; $9.7 ...

Read more →

Ottawa’s move to cut drug prices may lead to fewer new launches, less R&D

13 August 2019 - Health Canada is fundamentally changing how prescription drugs are priced in Canada.  ...

Read more →

Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned

13 August 2019 - Changes which aim to make prescriptions more affordable could shut off entry of new drugs. ...

Read more →

Canadian drug price regulator may be flexible on rare diseases

14 August 2019 - Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in ...

Read more →